Literature DB >> 28845134

Parkinson's Disease: What role do pedunculopontine nucleus cholinergic neurons play?

Nicolaas I Bohnen1,2,3, Martijn L T M Müller1, William T Dauer2, Roger L Albin2,3.   

Abstract

Entities:  

Keywords:  Acetylcholine; Parkinson’s disease; REM sleep behavior disorder; balance; cerebellum; pedunculopontine nucleus; thalamus

Year:  2013        PMID： 28845134      PMCID： PMC5568855          DOI： 10.2217/fnl.13.61

Source DB:  PubMed          Journal:  Future Neurol        ISSN： 1479-6708


× No keyword cloud information.
  20 in total

Review 1.  Nicotinic acetylcholine receptors: from basic science to therapeutics.

Authors:  Raymond Hurst; Hans Rollema; Daniel Bertrand
Journal:  Pharmacol Ther       Date:  2012-08-25       Impact factor: 12.310

2.  Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease.

Authors:  Kathryn A Chung; Brenna M Lobb; John G Nutt; Fay B Horak
Journal:  Neurology       Date:  2010-09-01       Impact factor: 9.910

3.  Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy.

Authors:  H Shinotoh; H Namba; M Yamaguchi; K Fukushi; S Nagatsuka; M Iyo; M Asahina; T Hattori; S Tanada; T Irie
Journal:  Ann Neurol       Date:  1999-07       Impact factor: 10.422

4.  Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.

Authors:  Ronald B Postuma; Josie-Anne Bertrand; Jacques Montplaisir; Catherine Desjardins; Mélanie Vendette; Silvia Rios Romenets; Michel Panisset; Jean-François Gagnon
Journal:  Mov Disord       Date:  2012-02-09       Impact factor: 10.338

5.  Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy.

Authors:  E C Hirsch; A M Graybiel; C Duyckaerts; F Javoy-Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Authors:  B F Boeve; M H Silber; T J Ferman; S C Lin; E E Benarroch; A M Schmeichel; J E Ahlskog; R J Caselli; S Jacobson; M Sabbagh; C Adler; B Woodruff; T G Beach; A Iranzo; E Gelpi; J Santamaria; E Tolosa; C Singer; D C Mash; C Luca; I Arnulf; C Duyckaerts; C H Schenck; M W Mahowald; Y Dauvilliers; N R Graff-Radford; Z K Wszolek; J E Parisi; B Dugger; M E Murray; D W Dickson
Journal:  Sleep Med       Date:  2013-03-07       Impact factor: 3.492

7.  Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.

Authors:  Philipp M Meyer; Karl Strecker; Kai Kendziorra; Georg Becker; Swen Hesse; Dominique Woelpl; Anke Hensel; Marianne Patt; Dietlind Sorger; Florian Wegner; Donald Lobsien; Henryk Barthel; Peter Brust; Hermann J Gertz; Osama Sabri; Johannes Schwarz
Journal:  Arch Gen Psychiatry       Date:  2009-08

8.  Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael R Kilbourn; Sid Gilman; Roger L Albin; Kirk A Frey
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-09       Impact factor: 6.200

9.  The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study.

Authors:  J Janzen; D van 't Ent; A W Lemstra; H W Berendse; F Barkhof; E M J Foncke
Journal:  J Neurol       Date:  2011-06-30       Impact factor: 4.849

10.  Topographical organization of the pedunculopontine nucleus.

Authors:  Cristina Martinez-Gonzalez; J Paul Bolam; Juan Mena-Segovia
Journal:  Front Neuroanat       Date:  2011-04-05       Impact factor: 3.856
View more
  1 in total

1.  Varenicline for the Treatment of Postural and Gait Dysfunction in Parkinson Disease.

Authors:  Sachin Kapur; Christina Vaughan; Jacob Hawkins; Glenn Stebbins; Deborah Hall
Journal:  Neurol Clin Pract       Date:  2021-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.